Our platform has developed based on a ground-breaking AI-driven approach to identify individuals at risk of developing cancers such as breast, prostate, colorectal, and cervical/ovarian cancers as well diabetes type 2. This pioneering study represents a world-first effort to integrate multiple screening modalities into a holistic framework, utilizing AI-based digital analysis to assess risk and identify high-risk cases for developing diseases.
Our AI-powered system can analyze ECG images and classify them into the following categories:
NORMAL ECG
ABNORMAL ECG